Cargando…

High signal intensity on T2 weighted cardiac magnetic resonance imaging in hypertrophic cardiomyopathy: Is it a marker of myocardial injury?

Detalles Bibliográficos
Autores principales:	Chen, Shi, Yong, Luo, Huang, Liwei, Sun, Jiayu, Zhang, Tianjing, Zhang, Qing, Chen, Yucheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328427/ http://dx.doi.org/10.1186/1532-429X-17-S1-P289

Ejemplares similares

T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2020)

The Value of Cardiac Magnetic Resonance Imaging in Identification of Rare Diseases Mimicking Hypertrophic Cardiomyopathy
por: Fang, Tingting, et al.
Publicado: (2021)

Phenotypic diversity identified by cardiac magnetic resonance in a large hypertrophic cardiomyopathy family with a single MYH7 mutation
por: Wang, Jie, et al.
Publicado: (2018)

Performance of 12‐lead electrocardiogram Selvester QRS scoring criteria to diagnose myocardial scar in patients with hypertrophic cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2020)

Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy
por: Dohy, Zsofia, et al.
Publicado: (2021)

Feature tracking (FT) and extracelluar volume (ECV) by cardiac magnetic resonance segmentally analyze change of LV in Ebstein:a novel perspective in myocardial remodeling
por: Yang, Dan, et al.
Publicado: (2016)

Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance
por: Raphael, Claire E., et al.
Publicado: (2016)

Mitral valve leaflet length as an important factor to differentiate hypertrophic cardiomyopathy from other causes of left ventricular hypertrophy
por: Luo, Yong, et al.
Publicado: (2016)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

High T2-weighted signal intensity is associated with myocardial deformation in hypertrophic cardiomyopathy
por: Shi, Ruo-yang, et al.
Publicado: (2019)

Cardiac Magnetic Resonance and Computed Tomography in Hypertrophic Cardiomyopathy: an Update
por: de Oliveira, Diogo Costa Leandro, et al.
Publicado: (2016)

Cardiac magnetic resonance imaging in the evaluation of patients with hypertrophic cardiomyopathy
por: Brenes, Juan Carlos, et al.
Publicado: (2018)

Post-Mortem Cardiac Magnetic Resonance for the Diagnosis of Hypertrophic Cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2020)

Tumoral Phenocopies of Hypertrophic Cardiomyopathy: The Role of Cardiac Magnetic Resonance
por: Bombace, Sara, et al.
Publicado: (2021)

Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance
por: Nguyen, Christopher, et al.
Publicado: (2015)

Cardiovascular Magnetic Resonance Imaging of Myocardial Interstitial Expansion in Hypertrophic Cardiomyopathy
por: Wong, Timothy C.
Publicado: (2014)

Progression of myocardial fibrosis and functional clinical status in Hypertrophic Cardiomyopathy: a study with cardiac magnetic resonance
por: Todiere, Giancarlo, et al.
Publicado: (2011)

Myocardial bridging in patients with hypertrophic cardiomyopathy is not associated with late gadolinium enhancement at cardiac magnetic resonance imaging
por: Hees, Tilman A, et al.
Publicado: (2013)

SARC Gene Mutation Is Associated With Myocardial Fibrosis Measured by Histopathology and Cardiac Magnetic Resonance in Patients With Hypertrophic Cardiomyopathy
por: Huang, Manyun, et al.
Publicado: (2023)

Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy
por: Huang, Shan, et al.
Publicado: (2022)

Cardiac Sarcoidosis Mimicking Hypertrophic Cardiomyopathy: The Importance of Cardiac Magnetic Resonance Imaging
por: Feldman, Daniel R., et al.
Publicado: (2020)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

The use of cardiac magnetic resonance imaging in diagnosing and characterizing hypertrophic cardiomyopathy
por: Ogele, Emmanuel, et al.
Publicado: (2016)

Role of Cardiac Magnetic Resonance in Detecting Biventricular Apical Hypertrophic Cardiomyopathy
por: Zaher, Nathan, et al.
Publicado: (2021)

Feature-tracking cardiac magnetic resonance method: a valuable marker of replacement fibrosis in hypertrophic cardiomyopathy
por: Rezaeian, Nahid, et al.
Publicado: (2022)

Abnormal T2-STIR Magnetic Resonance in Hypertrophic Cardiomyopathy: A Marker of Advanced Disease and Electrical Myocardial Instability
por: Todiere, Giancarlo, et al.
Publicado: (2014)

The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012)

Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy
por: Xu, Yuanwei, et al.
Publicado: (2020)

Impaired cardiac pump function assessment with normalized cardiac power using cardiac magnetic resonance in patients with hypertrophic cardiomyopathy
por: Li, Qing, et al.
Publicado: (2023)

Findings of Cardiac Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy after 16 Years
por: Kim, Gee-Hee, et al.
Publicado: (2016)

Correlation of Electrocardiographic Changes with Cardiac Magnetic Resonance Findings in Patients with Hypertrophic Cardiomyopathy
por: Paixão, Gabriela Miana de Mattos, et al.
Publicado: (2018)

Cardiac magnetic resonance in the assessment of hypertrophic cardiomyopathy phenotypes and stages – pictorial review
por: Stachera, Magdalena, et al.
Publicado: (2021)

Cardiac magnetic resonance-derived tissue tracking strain in patients with hypertrophic cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2022)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance
por: Stankowski, Kamil, et al.
Publicado: (2023)

Clinical Utility of Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy
por: Maron, Martin S
Publicado: (2012)

Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy
por: Chacko, Binita Riya, et al.
Publicado: (2018)

Relationship between electrocardiographic findings and Cardiac Magnetic Resonance phenotypes in patients with Hypertrophic Cardiomyopathy
por: Fronza, Matteo, et al.
Publicado: (2016)

QRS-T angle in patients with Hypertrophic Cardiomyopathy - A comparison with Cardiac Magnetic Resonance Imaging
por: Jensen, Christoph Julian, et al.
Publicado: (2021)

Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy
por: Sharifian, Maedeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jvu55oopqkvc8ngl4s16tslntk